沃华医药
(002107)
| 流通市值：38.85亿 | | | 总市值：39.25亿 |
| 流通股本：5.71亿 | | | 总股本：5.77亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 363,420,058.27 | 386,423,587.05 | 373,431,869.49 | 394,407,753.34 |
| 应收票据及应收账款 | 62,568,124.79 | 53,381,915.17 | 55,553,212.51 | 68,942,996.27 |
| 其中：应收票据 | 1,627,490.21 | 1,711,010.6 | 1,855,611.91 | 1,817,849.38 |
| 应收账款 | 60,940,634.58 | 51,670,904.57 | 53,697,600.6 | 67,125,146.89 |
| 应收款项融资 | 1,520,796.25 | 833,965.83 | 3,736,533.73 | 1,695,881.91 |
| 预付款项 | 3,262,267.69 | 3,050,682.03 | 3,869,430.62 | 2,353,770.45 |
| 其他应收款合计 | 2,364,174.74 | 2,743,022.34 | 2,884,490.82 | 1,321,316.88 |
| 存货 | 91,216,476.55 | 109,371,422.16 | 95,926,414.39 | 93,462,435.78 |
| 其他流动资产 | 3,801,776.57 | 3,994,301.68 | 4,077,285.61 | 4,586,782.04 |
| 流动资产合计 | 528,153,674.86 | 559,798,896.26 | 539,479,237.17 | 566,770,936.67 |
| 非流动资产: | | | | |
| 投资性房地产 | 16,390,619.61 | 16,571,307.96 | 16,751,996.31 | 16,932,684.66 |
| 固定资产 | 304,723,431.44 | 311,715,846.1 | 318,563,602.95 | 325,324,986.26 |
| 使用权资产 | 391,470.92 | 658,162.94 | 891,323.63 | 1,124,012.78 |
| 无形资产 | 33,466,991.06 | 33,757,899.11 | 34,048,807.16 | 34,339,715.21 |
| 商誉 | 32,508,664.53 | 32,508,664.53 | 32,508,664.53 | 32,508,664.53 |
| 递延所得税资产 | 365,758.65 | 322,914.59 | 348,443.28 | 355,467.09 |
| 其他非流动资产 | 347,200 | 264,050 | 47,884.88 | 13,500 |
| 非流动资产合计 | 388,194,136.21 | 395,798,845.23 | 403,160,722.74 | 410,599,030.53 |
| 资产总计 | 916,347,811.07 | 955,597,741.49 | 942,639,959.91 | 977,369,967.2 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 31,773,686.94 | 40,839,153.59 | 43,271,235.86 | 38,751,277.57 |
| 应付账款 | 31,773,686.94 | 40,839,153.59 | 43,271,235.86 | 38,751,277.57 |
| 预收款项 | 19,287.92 | 28,271.01 | 4,821.92 | 167,177.9 |
| 合同负债 | 3,200,986.04 | 2,265,382.31 | 3,406,875.33 | 5,276,684.48 |
| 应付职工薪酬 | 5,368,186.64 | 5,683,795.49 | 5,835,713.31 | 8,841,718.15 |
| 应交税费 | 15,245,821.83 | 15,558,538.14 | 17,677,125.5 | 13,311,512.7 |
| 其他应付款合计 | 43,137,270.6 | 39,851,108.05 | 39,000,362.96 | 37,545,758.63 |
| 一年内到期的非流动负债 | 511,628.52 | 788,775.18 | 1,062,646.97 | 920,311.6 |
| 其他流动负债 | 140,409,989.76 | 132,061,341.36 | 146,021,450.78 | 135,916,637.69 |
| 流动负债合计 | 239,666,858.25 | 237,076,365.13 | 256,280,232.63 | 240,731,078.72 |
| 非流动负债: | | | | |
| 租赁负债 | - | - | - | 233,380.88 |
| 长期应付职工薪酬 | 493,877.06 | 549,803.28 | 81,870.61 | 64,733.9 |
| 递延收益 | 9,624,520.1 | 10,328,929.07 | 11,033,338.04 | 11,737,747.01 |
| 递延所得税负债 | 3,501,247.81 | 3,510,032.64 | 3,694,147.81 | 3,702,932.64 |
| 非流动负债合计 | 13,619,644.97 | 14,388,764.99 | 14,809,356.46 | 15,738,794.43 |
| 负债合计 | 253,286,503.22 | 251,465,130.12 | 271,089,589.09 | 256,469,873.15 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 577,209,600 | 577,209,600 | 577,209,600 | 577,209,600 |
| 盈余公积 | 61,947,866.71 | 61,947,866.71 | 61,947,866.71 | 61,947,866.71 |
| 未分配利润 | 25,509,369.48 | 67,954,672.89 | 37,037,114.78 | 84,660,979.34 |
| 归属于母公司股东权益合计 | 664,666,836.19 | 707,112,139.6 | 676,194,581.49 | 723,818,446.05 |
| 少数股东权益 | -1,605,528.34 | -2,979,528.23 | -4,644,210.67 | -2,918,352 |
| 股东权益合计 | 663,061,307.85 | 704,132,611.37 | 671,550,370.82 | 720,900,094.05 |
| 负债和股东权益合计 | 916,347,811.07 | 955,597,741.49 | 942,639,959.91 | 977,369,967.2 |
| 公告日期 | 2026-10-10 | 2026-07-16 | 2026-04-08 | 2026-01-20 |
| 审计意见(境内) | | | | 标准无保留意见 |